Related scientific articles (all)

Validation of the EORTC QLQ-INFO 25 questionnaire in Lebanese cancer patients: Is ignorance a Bliss?

Authors : Tabchi S, El Rassy E, Khazaka A, El Karak F, Kourie HR, Chebib R, Assi T, Ghor M, Naamani L, Richa S, Ghosn M, Kattan J
Year : 2016
Journal : Qual Life Res
Volume : 25
Pages : 1597-604

Improved Survival of Calreticulin-Mutated Patients Compared With Janus Kinase 2 in Primary Myelofibrosis: A Meta-Analysis.

Authors : Kourie HR, Ameye L, Paesmans M, Bron D
Year : 2016
Journal : Clin Lymphoma Myeloma Leuk
Volume : 16(5)
Pages : 264-8

Endocrine treatment in breast cancer: Cure, resistance and beyond.

Authors : Tryfonidis K, Zardavas D, Katzenellenbogen BS, Piccart-Gebhart M
Year : 2016
Journal : Cancer Treat Rev
Volume : 50
Pages : 68-81

Pictilisib for oestrogen receptor-positive, aromatase inhibitor-resistant, advanced or metastatic breast cancer (FERGI): a randomised, double-blind, placebo-controlled, phase 2 trial.

Authors : Krop IE, Mayer IA, Ganju V, Dickler M, Johnston S, Morales S, Yardley DA, Melichar B, Forero-Torres A, Lee SC, de Boer R, Petrakova K, Vallentin S, Perez EA, Piccart-Gebhart M, Ellis M, Winer E, Gendreau S, Derynck M, Lackner M, Levy G, Qiu J, He J, Schmid P
Year : 2016
Journal : Lancet Oncol
Volume : 17
Pages : 811-21

Histological transformation of ALK rearranged adenocarcinoma into small cell lung cancer: A new mechanism of resistance to ALK inhibitors.

Authors : Levacq D, DHaene N, de Wind R, Remmelink M, Berghmans T
Year : 2016
Journal : Lung Cancer
Volume : 102
Pages : 38-41

The current use and attitudes towards tumor genome sequencing in breast cancer.

Authors : Gingras I, Sonnenblick A, de Azambuja E, Paesmans M, Delaloge S, Aftimos P, Piccart-Gebhart M, Sotiriou C, Ignatiadis M, Azim HA Jr
Year : 2016
Journal : Sci Rep
Volume : 6
Pages : 22517

Reply to the letter to the editor 'Utilisation of the ESMO-MCBS in practice of HTA' by Wild et al.

Authors : Cherny NI, Sullivan R, Dafni U, Bogaerts J, Kerst JM, Zielinski C, Piccart-Gebhart M, de Vries EG
Year : 2016
Journal : Ann Oncol
Volume : 27(11)
Pages : 2136-7

Faut-il réévaluer les indications pour l’utilisation des facteurs stimulant la granulopoïèse en fonction des comorbidités présentées par les patients?

Authors : Klastersky J, Paesmans M
Year : 2016
Journal : Onco-Hémato
Volume : -
Pages : 4 pages

Lapatinib-Related Rash and Breast Cancer Outcome in the ALTTO Phase III Randomized Trial.

Authors : Sonnenblick A, de Azambuja E, Agbor-Tarh D, Bradbury I, Campbell C, Huang Y, Dueck AC, Pritchard KI, Wolff AC, Jackisch C, Lang I, Untch M, Smith I, Boyle F, Xu B, Gomez H, Perez EA, Piccart-Gebhart M, Azim HA Jr
Year : 2016
Journal : J Natl Cancer Inst
Volume : 108

Feasibility Study of EndoTAG-1, a Tumor Endothelial Targeting Agent, in Combination with Paclitaxel followed by FEC as Induction Therapy in HER2-Negative Breast Cancer.

Authors : Ignatiadis M, Zardavas D, Lemort M, Wilke C, Vanderbeeken MC, Dhondt V, de Azambuja E, Gombos A, Lebrun F, Dal Lago L, Bustin F, Maetens M, Ameye L, Veys I, Michiels S, Paesmans M, Larsimont D, Sotiriou C, Nogaret JM, Piccart-Gebhart M, Awada A
Year : 2016
Journal : PLoS One
Volume : 11(7)
Pages : e0154009

Side-effects of checkpoint inhibitor-based combination therapy.

Authors : Kourie HR, Klastersky J
Year : 2016
Journal : Curr Opin Oncol
Volume : 28
Pages : 306.13

New generation of breast cancer clinical trials implementing molecular profiling.

Authors : Zardavas D, Piccart-Gebhart M
Year : 2016
Journal : Cancer Biol Med
Volume : 13
Pages : 226-35

The emerging problem of bacterial resistance in cancer patients; proceedings of a workshop held by MASCC Neutropenia, Infection and Myelosuppression" Study Group during the MASCC annual meeting held in Berlin on 27-29 June 2013."

Authors : Rapoport B, Klastersky J, Raftopoulos H, Freifeld A, Aoun M, Zinner SH, Rolston KV
Year : 2016
Journal : Support Care Cancer
Volume : 24(7)
Pages : 2819-26

Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial.

Authors : Piccart-Gebhart M, Holmes E, Baselga J, de Azambuja E, Dueck AC, Viale G, Zujewski JA, Goldhirsch A, Armour A, Pritchard KI, McCullough AE, Dolci S, Mcfadden E, Holmes AP, Tonghua L, Eidtmann H, Dinh P, Di Cosimo S, Harbeck N, Tjulandin S, Im YH, Huang CS, Diéras V, Hillman DW, Wolff AC, Jackisch C, Lang I, Untch M, Smith I, Boyle F, Xu B, Gomez H, Suter T, Gelber Rd, Perez EA
Year : 2016
Journal : J Clin Oncol
Volume : 34(10)
Pages : 1034-42

An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers.

Authors : Bottai G, Raschioni C, Losurdo A, Di Tommaso L, Tinterri C, Torrisi R, Reis-Filho JS, Roncalli M, Sotiriou C, Santoro A, Mantovani A, Loi S, Santarpia L
Year : 2016
Journal : Breast Cancer Res
Volume : 18
Pages : 121

The genomic landscape of breast cancer and its interaction with host immunity.

Authors : Luen S, Virassamy B, Savas P, Salgado R, Loi S
Year : 2016
Journal : Breast
Volume : 29
Pages : 241-50

Nasopharyngeal adenoid cystic carcinoma, a rare but highly challenging disease with unmet therapeutic needs: A case-report and review of the literature].

Authors : Afani L, Errihani H, Benchafai I, Lalami Y
Year : 2016
Journal : Cancer Radiother
Volume : 20(5)
Pages : 400-4

Clinical research in febrile neutropenia in cancer patients: Past achievements and perspectives for the future

Authors : Klastersky J, Paesmans M, Aoun M, Georgala A, Loizidou A, Lalami Y, Dal Lago L
Year : 2016
Journal : World J Clin Infect Dis
Volume : 6(3)
Pages : 37-60

Adding checkpoint inhibitors to tyrosine kinase inhibitors targeting EGFR/ALK in non-small cell lung cancer: a new therapeutic strategy.

Authors : Tabchi S, Kourie HR, Kattan J
Year : 2016
Journal : Invest New Drugs
Volume : 34(6)
Pages : 794-6

Phase I Study of the Prolactin Receptor Antagonist LFA102 in Metastatic Breast and Castration-Resistant Prostate Cancer.

Authors : Agarwal N, Machiels JP, Suárez C, Lewis N, Higgins M, Wisinski K, Awada A, Maur M, Stein M, Hwang A, Mosher R, Wasserman E, Wu G, Zhang H, Zieba R, Elmeliegy M
Year : 2016
Journal : Oncologist
Volume : 21(5)
Pages : 535-6